Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (221-230 of 284) with videos related to

Pageof 29
Sort By:
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Journal of Virology|February 28, 2006
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletionMichele Di Mascio, Irini Sereti, Lynn T Matthews, et al.
Science Translational Medicine|August 9, 2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse modelKim Anthony-Gonda, Ariola Bardhi, Alex Ray, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Journal of Virology|August 17, 2004
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibodyMei-Yun Zhang, Xiaodong Xiao, Igor A Sidorov, et al.
Plos Pathogens|November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infectionKatharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
Pageof 29

Showing results (221-230 of 284) with videos related to

Sort By:
Pageof 29
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Journal of Virology|February 28, 2006
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletionMichele Di Mascio, Irini Sereti, Lynn T Matthews, et al.
Science Translational Medicine|August 9, 2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse modelKim Anthony-Gonda, Ariola Bardhi, Alex Ray, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Journal of Virology|August 17, 2004
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibodyMei-Yun Zhang, Xiaodong Xiao, Igor A Sidorov, et al.
Plos Pathogens|November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infectionKatharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
Pageof 29